The Margin Illusion

Is Your Healthcare Business Really Profitable?

A specialty clinic reports a healthy margin.

Patient volumes are growing.

The service line appears ready for further investment.

But its staff rely on centralized administration. Its marketing is funded by the group. Its technology costs sit in the corporate budget. Senior clinical leaders spend hours resolving its operational problems.

If those costs were fully attributed to the service line, would it still look like a winner?

The subsidy behind the margin is the cost carried elsewhere to make a business appear more profitable than its full economic contribution suggests.

The problem is not necessarily inaccurate accounting. It is that the figures used to evaluate individual services may not reveal the economics of the wider organization.

When One Service Line Wins at Another’s Expense

Imagine a healthcare group deciding which specialty to expand.

Specialty A reports a strong margin because several essential support functions are funded centrally.

Specialty B appears less profitable because it carries more of its own staffing and operational costs.

Leadership allocates more capital to Specialty A.

But what if Specialty A consumes disproportionate executive attention, requires extensive scheduling support, or depends on shared clinical resources that constrain other services?

The comparison may be misleading.

Three forms of hidden subsidy deserve scrutiny:

• Shared-service subsidy: One service benefits from administration, finance, HR, IT, or compliance resources whose full costs are not reflected in its results.

• Capacity subsidy: A service consumes scarce clinical or operational capacity without accounting for the value of the alternative work that capacity could support.

• Leadership subsidy: Senior leaders repeatedly intervene to sustain a service, absorbing time that could otherwise be invested in enterprise priorities.
  

These costs do not automatically make a service unattractive. Shared infrastructure can be economically efficient, and centralized functions often benefit the entire organization. The issue is whether leaders understand the real costs, the value created, and the trade-offs involved.

The Danger of Ranking What Is Not Comparable

Reported margin is useful—but it is not the whole investment case.

In “What Is Strategy?” (Harvard Business Review, November–December 1996), Michael E. Porter emphasizes that competitive advantage depends on the fit among activities, not simply the performance of isolated components. For healthcare groups, that means evaluating how service lines use and reinforce shared capabilities—not treating every margin figure as if it exists independently.

A service with a lower standalone margin may attract patients who use other profitable services. Another may generate excellent direct returns but require expensive infrastructure or scarce specialist capacity. A third may be strategically important despite having a different financial profile.

The board’s task is not to eliminate every subsidy. It is to distinguish deliberate cross-subsidization from accidental cost shifting.

Deliberate cross-subsidization can support access, strategic positioning, or a broader patient-care model. Accidental cost shifting can make weak economics look strong and direct investment toward the wrong priorities.

Five Questions Before the Next Investment

Before expanding a specialty or comparing service-line performance, CEOs and boards should ask:

1. What is the true cost of this service? Include relevant shared services, facilities, technology, and management support.

2. Who is absorbing the unrecorded workload? Identify the teams and specialists whose capacity is being consumed.

3. What would happen if this service paid for the resources it actually uses? Would its economics and investment priority change?

4. Is the subsidy intentional? If one service supports another, is that a deliberate strategic choice with a defined rationale—or an unintended result of how costs are allocated?

5. What is the opportunity cost of keeping this arrangement? Could the same resources create greater value elsewhere?

These questions matter particularly when UAE healthcare groups assess new specialties, compare clinic performance, consider acquisitions, or decide which locations deserve further capital.

Make the Economics Visible Before Capital Moves

Sophisticated allocation requires more than a league table of service-line margins. Leaders need a consistent view of direct costs, shared-resource consumption, capacity constraints, and the strategic benefits that may not appear in a conventional profit-and-loss statement.

That does not mean distributing every corporate expense mechanically across departments.

Arbitrary allocations can create a different distortion. The objective is to make material costs and trade-offs visible, use defensible allocation methods, and distinguish financial contribution from strategic value.

Phoenix MedStrategy helps healthcare leaders examine service-line economics alongside operational dependencies and strategic priorities—so investment decisions are based on what the organization truly gains, not simply where costs are recorded.

The executive test: If every service line carried the true cost of the resources it consumes, would your growth priorities remain the same?

A strong margin is a useful signal. Understanding what sustains it is a leadership responsibility.

Sources

Porter, Michael E. “What Is Strategy?” Harvard Business Review, November–December 1996.

Kaplan, Robert S., and David P. Norton. The Balanced Scorecard: Translating Strategy into Action. Harvard Business School Press, 1996.

Drury, Colin. Management and Cost Accounting. Cengage Learning. (Reference for cost allocation, contribution analysis, and management accounting principles.)